Published Online
on August 17, 2009

A more recent version of this article appeared on September 1, 2009

This Article Full Text (PDF) All Versions of this Article: 120/9/719    most recent CIRCULATIONAHA.109.888529v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Mark, A. L. PubMed PubMed Citation Articles by Mark, A. L. Pubmed/NCBI databases Medline Plus Health Information Obesity Related Collections Obesity Other hypertension Related Article

Submitted on ,
Accepted on ,

Cardiovascular Side Effects of Antiobesity Drugs. A Yellow Flag in the Race to Safe Pharmacotherapy for Obesity

Allyn L. Mark MD^*

From the Center on Functional Genomics of Hypertension and Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

^* To whom correspondence should be addressed. E-mail: allyn-mark{at}uiowa.edu.

Key words: Editorials • obesity • blood pressure • nervous system- sympathetic • leptin

Related Article:

Protein Tyrosine Phosphatase 1B, a Major Regulator of Leptin-Mediated Control of Cardiovascular Function

Eric J. Belin de Chantemèle, Kenjiro Muta, James Mintz, Michel L. Tremblay, Mario B. Marrero, David J. Fulton, and David W. Stepp
Circulation 2009 120: 753-763. [Abstract] [Full Text]